Buprenorphine transdermal skin patch and Ruxolitinib Phosphate
Determining the interaction of Buprenorphine transdermal skin patch and Ruxolitinib Phosphate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: ruxolitinib
Brand name: Jakafi
Synonyms: Ruxolitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Ruzurgi
- Buprenorphine transdermal skin patch-Ryanodex
- Buprenorphine transdermal skin patch-Rybelsus
- Buprenorphine transdermal skin patch-Rybix ODT
- Buprenorphine transdermal skin patch-RyClora
- Buprenorphine transdermal skin patch-Rydapt
- Ruxolitinib Phosphate-Buprenorphine, Buprenorphine Hydrochloride
- Ruxolitinib Phosphate-Buprenorphine/naloxone Oromucosal, Sublingual
- Ruxolitinib Phosphate-Buproban
- Ruxolitinib Phosphate-Bupropion
- Ruxolitinib Phosphate-Bupropion and naltrexone
- Ruxolitinib Phosphate-Bupropion Extended-Release Tablets